NCT03662789View on ClinicalTrials.gov

Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

April 25, 2018

Primary Completion Date

February 27, 2020

Study Completion Date

February 27, 2020

Conditions

Heart Transplant Recipients

Interventions

DRUG

Iron Isomaltoside 1000

Intravenous infusion

OTHER

Placebo: NaCl 0,9%

Intravenous infusion

Trial Locations (1)

0372

Oslo university Hospital, Rikshospitalet, Oslo

Sponsors

Collaborators (1)

Pharmacosmos A/S

All Listed Sponsors

collaborator

Pharmacosmos A/S

INDUSTRY

lead

Oslo University Hospital

OTHER